[Laparoscopic transhiatal esophagectomy: outcomes]. / Esofagectomia laparocópica transhiatal: resultados imediatos.

BACKGROUND: The laparoscopic transhiatal esophagectomy for benign or malignant disease is a complex operation associated with a high rate of morbidity and mortality. In the last decade this procedure gained popularity and acceptance for treatment of the esophagus cancer and other benign diseases. AIM: To perform a retrospective analysis in patients with esophageal cancer that was underwent a laparoscopic transhiatal esophagectomy, demonstrated pre and post operative complications and immediate result. METHODS: From November 1993 to June 2005, 72 patients underwent laparoscopic transhiatal esophagectomy. Sixty-four with malignant neoplasm of esophagus. The males are predominant, and the mean age was 56.5 years. The abdominal part of the operation was totally laparoscopic and the cervical one was made the conventional way. The stomach was pulled up to the neck by the posterior mediastinum. RESULTS: The laparoscopic transhiatal esophagectomy was initiated in 64 patients. Four patients were converted to open surgery. The mean operation time was 153 minutes. The incidence of cervical fistula was 14.06%. The mortality rate 5.6%. CONCLUSION: Laparoscopic transhiatal esophagectomy is a secure option in experience centers. The morbility is low, with a faster return to normal activity. Maybe in fact this procedure may be reminded and ponder in the treatment of esophageal disease.

Diabetes and cardiovascular events in high-risk patients: Insights from a multicenter registry in a middle-income country.

AIMS: The aim of this study was to determine the rate of major clinical events and its determinants in patients with previous cardiovascular event or not, and with or without diabetes from a middle-income country. METHODS: REACT study is a multicenter registry conducted between July 2010 and May 2013 in Brazil. Patients were eligible if they were over 45years old and high cardiovascular risk. Patients were followed for 12months; data were collected regarding adherence to evidence-based therapies and occurrence of clinical events (all-cause mortality, non-fatal cardiac arrest, myocardial infarction, or stroke). RESULTS: A total of 5006 subjects was included and analyzed in four groups: No diabetes and no previous cardiovascular event, n=430; diabetes and no previous cardiovascular event, n=1138; no diabetes and previous cardiovascular event, n=1747; and diabetes and previous cardiovascular event, n=1691. Major clinical events in one-year follow-up occurred in 332 patients. A previous cardiovascular event was associated with a higher risk of having another event in the follow-up (HR 2.31 95% CI 1.74-3.05, p<0.001), as did the presence of diabetes (HR 1.28 95% CI 1.10-1.73, p=0.005). In patients with diabetes,failure to reach HbA1c targetswas related topoorer event-free survival compared to patients with good metabolic control (HR 1.70 95% CI 1.01-2.84, p=0.044). CONCLUSIONS: In Brazil, diabetes confers high risk for major clinical events, but this condition is not equivalent to having a previous cardiovascular event. Moreover, not so strict targets for HbA1c in patients with diabetes and previous cardiovascular events might be considered.

Heart Rate Variability Correlates to Functional Aerobic Impairment in Hemodialysis Patients.

BACKGROUND: Autonomic dysfunction (AD) is highly prevalent in hemodialysis (HD) patients and has been implicated in their increased risk of cardiovascular mortality. OBJECTIVE: To correlate heart rate variability (HRV) during exercise treadmill test (ETT) with the values obtained when measuring functional aerobic impairment (FAI) in HD patients and controls. METHODS: Cross-sectional study involving HD patients and a control group. Clinical examination, blood sampling, transthoracic echocardiogram, 24-hour Holter, and ETT were performed. A symptom-limited ramp treadmill protocol with active recovery was employed. Heart rate variability was evaluated in time domain at exercise and recovery periods. RESULTS: Forty-one HD patients and 41 controls concluded the study. HD patients had higher FAI and lower HRV than controls (p<0.001 for both). A correlation was found between exercise HRV (SDNN) and FAI in both groups. This association was independent of age, sex, smoking, body mass index, diabetes, and clonidine or beta-blocker use, but not of hemoglobin levels. CONCLUSION: No association was found between FAI and HRV on 24-hour Holter or at the recovery period of ETT. Of note, exercise HRV was inversely correlated with FAI in HD patients and controls.

ß-adrenergic receptor polymorphisms in susceptibility, response to treatment and prognosis in heart failure: implication of ethnicity.

Common functional polymorphisms in ß-adrenergic receptor (ßAR) genes have been associated with heart failure (HF) phenotypes and pharmacogenetic interactions with ßAR blockers. This study evaluated the association between ßAR polymorphisms and carvedilol drug response and prognosis in patients with HF. In this prospective cohort controlled study, 326 volunteers were enrolled [146 HF patients (ejection fraction (EF)<50% by Simpson) and 180 healthy controls]. Drug response was evaluated by echocardiography and outcomes were mortality and hospitalization. DNA was extracted from peripheral blood leukocytes, fragments were amplified by the polymerase reaction and genotyped by restriction fragment length polymorphism (RFLP) for Ser49Gly and Arg389Gly ßAR-1 polymorphisms and Gln27Glu and Arg16Gly ßAR-2 polymorphisms. The study population was in Hardy­Weinberg equilibrium. The survival rate was adjusted using the Kaplan-Meier method. HF patients showed the following characteristics: EF 35±9%, 69.9% male, age 59±13 years, 50.7% self-identified as black, 46% had ischemic etiology. The mean follow-up of 23 months showed 18 mortalities and 46 hospitalizations. The genotypes Glu27Glu (24.7 vs. 6.1%, p=0.0004) and Arg16Arg (72.6 vs. 22.8, p<0.0001) of ßAR2 polymorphisms and Gly49Gly (33.6 vs. 4.3%, p<0.0001) of the ßAR1 polymorphism were higher in HF patients compared with controls. Patients with hospital admission showed a significantly higher Gly389 allelic frequency (54.9 vs. 42.1%, p=0.039), and the trend prevailed among patients who succumbed to the disease (61.1%, p=0.047). Black patients with the Ser49Ser genotype showed a reduced survival compared with the Gly49Gly or Ser49Gly genotypes (p=0.028). There was no association between improved LVEF >20% and ßAR polymorphisms. HF patients with ß-blocker therapy and the Gly389 allele have reduced event-free survival compared to those carrying the Arg389 allele. Additionally, systolic HF outpatients undergoing ß-blocker therapy, self­identified as black and homozygous for Ser49Ser may have reduced event-free survival, while Glu27Glu, Arg16Arg and Gly49Gly genotypes may be associated with risk for HF.

Influence on prognosis and prevalence of stress hyperglycemia in a cohort of patients with acute coronary syndrome.

OBJECTIVE: To demonstrate the prevalence of stress hyperglycemia in a cohort of patients with acute coronary syndrome and to determine the correlation of stress hyperglycemia with death, heart failure and/or left ventricular systolic dysfunction during the intrahospital phase. METHODS: A prospective initial cohort study of hospitalized patients with acute coronary syndrome with or without ST segment elevation. The groups were compared to demonstrate the correlation between stress hyperglycemia and cardiovascular events. The chi-square test or Fisher's exact test and student's t-test were used to compare the groups with and without stress hyperglycemia. The variables with p<0.20 in the univariate analysis were submitted to logistic regression. RESULTS: In total, 363 patients with an average age of 12.45 ± 62.06 were studied. There was a predominance of males (64.2%). In total, 96 patients (26.4%) presented with stress hyperglycemia. There were no differences between the groups with or without stress hyperglycemia. The area under the ROC curve was 0.67 for the relationship between stress hyperglycemia and the composite outcome heart failure, left ventricular systolic dysfunction or death at the end of the hospital admission. The ROC curve proved that stress hyperglycemia was the predictor of the composite outcome (death, heart failure and/or ventricular dysfunction). The multivariate analysis did not indicate age, stress hyperglycemia or admission heart rate as risk factors. CONCLUSION: Stress hyperglycemia was common in the studied sample. In the univariate analysis, the presence of stress hyperglycemia was associated with such events as death, heart failure and/or intrahospital ventricular dysfunction in patients with acute coronary syndrome.

Prevalence and variables predictive of depressive symptoms in patients hospitalized for heart failure.

BACKGROUND: Our study set out to determine the prevalence of depressive symptoms and variables that influence its presence in patients hospitalized for heart failure. Depression is associated with a substantially increased risk of developing heart failure in individuals at risk, and has been related to adverse outcomes in patients with established heart failure. It is important to determine its prevalence in different populations and assess related causes. METHODS: We conducted a cross-sectional study of 103 patients with heart failure, admitted to public hospital, via a questionnaire that evaluates clinical variables, socio-demographics and we applied the Beck Depression Inventory to determine the prevalence of depressive symptoms and predictors of their presence. We used the chi2, Student test and considered significant when < 0.05 and subjected to logistic regression analysis when between 0.05 and 0.1. RESULTS: The mean age of the patients in our study was 65.4 ± 13.6. Depressive symptoms were present in 69 (67%) patients: 35 (34%) had mild depressive symptoms, 22 (21.3%) had moderate symptoms and 12 (11.6%) patients presented severe symptoms. Marital status was significant when analyzed, and the predictors of depressive symptoms were marital status, sex, living arrangements and heart failure etiology. CONCLUSIONS: Because depressive symptoms in patients hospitalized for heart failure are very common, it is important to detect these disorders. The prevalence of these varies according to socio-demographic and clinical data, and these factors should be taken into consideration when planning future studies, as well as screening and intervention programs for co-morbid depressive disorders in hospitalized patients with heart failure.

Sociodemographic factors and depressive symptoms in hospitalized patients with heart failure.

OBJECTIVE: To determine the differences in depressive symptoms (DS) among a sample of patients hospitalized with heart failure (HF). DESIGN: A descriptive, cross-sectional design was used. METHODS: The Beck Depression Inventory was used to measure DS, and HF severity was assessed using the New York Heart Association (NYHA) classification system. The sociodemographic and clinical variables examined include age, sex, education, marital status, fixed monthly income, habitation, living arrangement and HF severity. The differences between the presence and absence of the variables were evaluated using the Student's t test. RESULTS: The sample included 103 patients with a mean age of 65.4 years: 38 (36.9%) were men and 65 (63.1%) were women. Forty-three patients (41.7%) were in NYHA class III, and approximately one-half of the patient sample (49.5%) were married. Patients with NYHA class IV HF had significantly more DS than patients with NYHA class II or III. Age was correlated with scores of DS (P=0.002). There were significant differences in DS among the variables of marital status, habitation and living arrangement. CONCLUSIONS: Depression is a common and treatable clinical finding in hospitalized patients, requiring an early diagnosis and appropriate treatment for effective management. The implementation and monitoring of treatment are necessary to reduce the costs of treatment of HF.

Analysis of specific pre-operative model to valve surgery and relationship with the length of stay in intensive care unit. / Análise de um modelo de risco pré-operatório específico para cirurgia valvar e a relação com o tempo de internação em unidade de terapia intensiva.

OBJECTIVES: The length of stay after prolonged cardiac surgery has been associated with poor immediate outcomes and increased costs. This study aimed to evaluate the predictive power of the Ambler Score to anticipate the length of stay in the intensive care unit. METHODS: This was a retrospective cohort study based on data collected from 110 patients undergoing valve replacement surgery alone or in combination with other procedures. Additive and logistic Ambler Scores were obtained and their predictive performances calculated using the Receiver Operating Characteristic curve. The normal length stay in the intensive care unit was assumed to be <3 days and prolonged >3 days. The areas under the receiver operating curves for both the additive and logistic models were compared using the Hanley-MacNeil test. RESULTS: The mean intensive care unit length of stay was 4.2 days. Sixty-three patients were male. The logistic model showed areas under the receiver operating characteristic curve of 0.73 and 0.79 for hospitalization > 3 days and < 3 days, respectively, showing good discriminative power. For the additive model, the areas were 0.63 and 0.59 for hospitalization > 3 days and < 3 days, respectively, a poor discriminative power. CONCLUSIONS: In our database, prolonged length of stay in the intensive care unit was positively correlated with the logistic Ambler score. The performance of the logistic Ambler Score had good discriminative power for correlation with the intensive care unit length of stay.

Heart Rate Variability Correlates to Functional Aerobic Impairment in Hemodialysis Patients / Variabilidade RR ao Esforço Correlaciona-se com Déficit Funcional Aeróbico em Pacientes em Hemodiálise

Background: Autonomic dysfunction (AD) is highly prevalent in hemodialysis (HD) patients and has been implicated in their increased risk of cardiovascular mortality. Objective: To correlate heart rate variability (HRV) during exercise treadmill test (ETT) with the values obtained when measuring functional aerobic impairment (FAI) in HD patients and controls. Methods: Cross-sectional study involving HD patients and a control group. Clinical examination, blood sampling, transthoracic echocardiogram, 24-hour Holter, and ETT were performed. A symptom-limited ramp treadmill protocol with active recovery was employed. Heart rate variability was evaluated in time domain at exercise and recovery periods. Results: Forty-one HD patients and 41 controls concluded the study. HD patients had higher FAI and lower HRV than controls (p<0.001 for both). A correlation was found between exercise HRV (SDNN) and FAI in both groups. This association was independent of age, sex, smoking, body mass index, diabetes, and clonidine or beta-blocker use, but not of hemoglobin levels. Conclusion: No association was found between FAI and HRV on 24-hour Holter or at the recovery period of ETT. Of note, exercise HRV was inversely correlated with FAI in HD patients and controls. (Arq Bras Cardiol. 2015; [online]. ahead print, PP.0-0) .

Fundamento: A disfunção autonômica (DA) é altamente prevalente em pacientes em hemodiálise (HD) e tem sido implicada no risco aumentado de mortalidade cardiovascular. Objetivo: Correlacionar a variabilidade RR (VRR) durante o teste ergométrico (TE) com o déficit funcional aeróbico (FAI) em pacientes em HD e em um grupo controle. Métodos: Trata-se de um estudo transversal no qual as variáveis analisadas foram obtidas através de exame clínico, coleta de sangue, ecocardiograma transtorácico, Holter de 24 horas e TE. Foi realizado TE em esteira pelo protocolo de rampa, limitado por sintomas, com recuperação ativa. A VRR foi avaliada no domínio do tempo no exercício e na recuperação separadamente. Resultados: Quarenta e um pacientes em HD e 41 controles concluíram o estudo. Pacientes em HD tinham maior FAI e menor VRR do que os controles (p <0,001 para ambos). Houve correlação entre FAI e VRR no exercício (SDNN) em ambos os grupos. Esta associação foi independente de idade, sexo, tabagismo, índice de massa corporal, diabetes, clonidina, betabloqueador, mas não dos níveis de hemoglobina. Conclusão: A VRR no exercício foi inversamente correlacionada com o FAI em pacientes em HD e controles. Não foram observadas associações do FAI com VRR no Holter ou no período de recuperação do TE. .

Prevalência e influência da hiperglicemia de estresse no prognóstico em uma coorte de pacientes com síndrome coronariana aguda / Influence on prognosis and prevalence of stress hyperglycemia in a cohort of patients with acute coronary syndrome

OBJETIVO: Demonstrar a prevalência da hiperglicemia de estresse em coorte de pacientes com síndrome coronariana aguda e a correlação com óbito, insuficiência cardíaca e/ou disfunção ventricular esquerda sistólica, na fase intra-hospitalar. MÉTODOS: Estudo de coorte prospectiva inicial constituída por pacientes internados com síndrome coronariana aguda, com ou sem supradesnivelamento do segmento ST. Foram comparados os grupos para demonstrar a correlação entre hiperglicemia de estresse e eventos cardiovasculares. Na comparação entre os grupos com e sem hiperglicemia de estresse, foram usados o teste do qui-quadrado ou exato de Fisher, e o teste t de student. As variáveis com valor de p<0,20 na análise univariada foram submetidas à regressão logística variáveis. RESULTADOS: Foram estudados 363 pacientes com média etária de 62,06±12,45 anos, com predomínio do gênero masculino (64,2%). O total de 96 pacientes (26,4%) apresentou hiperglicemia de estresse. Não houve diferenças entre os grupos com ou sem hiperglicemia de estresse. A área sobre a curva ROC foi de 0,67 para relação entre a hiperglicemia de estresse e o desfecho composto insuficiência cardíaca, disfunção sistólica de ventrículo esquerdo ou óbito ao fim da internação. A curva ROC mostrou ser a hiperglicemia de estresse fator preditivo do desfecho composto (óbito, insuficiência cardíaca e/ou disfunção ventricular). A análise multivariada não apontou fator de risco a idade, hiperglicemia de estresse ou frequência cardíaca de admissão. CONCLUSÃO: A hiperglicemia de estresse na amostra estudada foi frequente. Sua presença associou-se, na análise univariada, com eventos como óbito, insuficiência cardíaca e/ou disfunção ventricular na fase intra-hospitalar, em pacientes com síndrome coronariana aguda.

OBJECTIVE: To demonstrate the prevalence of stress hyperglycemia in a cohort of patients with acute coronary syndrome and to determine the correlation of stress hyperglycemia with death, heart failure and/or left ventricular systolic dysfunction during the intrahospital phase. METHODS: A prospective initial cohort study of hospitalized patients with acute coronary syndrome with or without ST segment elevation. The groups were compared to demonstrate the correlation between stress hyperglycemia and cardiovascular events. The chi-square test or Fisher's exact test and student's t-test were used to compare the groups with and without stress hyperglycemia. The variables with p<0.20 in the univariate analysis were submitted to logistic regression. RESULTS: In total, 363 patients with an average age of 12.45 ± 62.06 were studied. There was a predominance of males (64.2%). In total, 96 patients (26.4%) presented with stress hyperglycemia. There were no differences between the groups with or without stress hyperglycemia. The area under the ROC curve was 0.67 for the relationship between stress hyperglycemia and the composite outcome heart failure, left ventricular systolic dysfunction or death at the end of the hospital admission. The ROC curve proved that stress hyperglycemia was the predictor of the composite outcome (death, heart failure and/or ventricular dysfunction). The multivariate analysis did not indicate age, stress hyperglycemia or admission heart rate as risk factors. CONCLUSION: Stress hyperglycemia was common in the studied sample. In the univariate analysis, the presence of stress hyperglycemia was associated with such events as death, heart failure and/or intrahospital ventricular dysfunction in patients with acute coronary syndrome.

Diagnóstico angiográfico da ruptura de parede livre do ventrículo esquerdo noinfarto agudo do miocárdio / Angiographic diagnosis of ruptured left ventricular free wall in acute myocardial infarction

Paciente do sexo masculino com precordialgia típica foi admitido com delta T de 8 horas e diagnóstico de infarto do miocárdio com supradesnivelamento do ST dep a rede a n t e r i o r. F o i e n caminhado paracineangiocoronariografia para realização de angioplastia primária e observou-se oclusão total da descendente anterior e de 90% na coronária direita, sem sucesso. Durante o procedimento piora do quadro clínico com sinais de tamponamento cardíaco e a ventriculografia demonstrou ruptura de parede de ventrículo esquerdo.Realizada punção pericárdica com alívio dos sintomas. Foi indicado o tratamento cirúrgico que evoluiu sem sucesso e o paciente foi a óbito.

Síndrome de Eisenmenger em paciente com comunicação interatrial: A propósito de um caso

A síndrome de Eisenmenger (SE) representa a forma mais avançada da hipertensão arterial pulmonar associada a defeitos cardíacos congênitos (DCC). Os adultos com DCC representam uma população em expansão que requerem cuidados médicos terciários a longo prazo. Em torno de 8% dos pacientes com DCC e 11% daqueles com shunt da esquerda para direita desenvolvem o quadro da SE. Os esforços no tratamento são direcionados para redução da resistência vascular pulmonar, shunt da esquerda para direita, cianose, morbidade e mortalidade. Apresentamos caso do sexo feminino, 41 anos, que apresentou quadro de cianose de repouso, edema de membros inferiores e defeito de septo atrial do tipo comunicação interatrial diagnosticado na ecocardiografia que foi abordado de forma medicamentosa com bloqueadores de canal de cálcio.

Aspectos farmacogenéticos associados à resistência terapêutica antiplaquetária em pacientes com síndrome coronariana aguda / Pharmacogenetic aspects associated with anti-platelet therapy resistance in patients with acute coronary syndrome

O uso de medicamentos que inibem a função plaquetária reduz significativamente as complicações isquêmicas com síndromes coronarianas agudas (SCA) e naqueles submetidos à intervenção coronariana percutânea (ICP) com stent. Apesar de toda a evoluçao da terapêutica antiplaquetária, os fenômenos trombóticos continuam a ocorrer e, embora suas causas determinantes sejam múltiplas, cresce o conceito de resistência terapêutica antiplaquetária, melhor entendida como a baixa resposta ou mesmo a ausência desta ao uso dos antiplaquetários, que pode refletir aspectos farmacológicos e farmacocinéticos de cada medicamento. A resistência antiplaquetária pode ser classificada em laboratórial ou clínica. A resistência laboratorial é definida como a falha do medicamento em inibir a função plaquetária ex vivo. A resistência clínica é definida como a falha do medicamento em prevenir a ocorrência de eventos adversos cardiovasculares em pacientes com SCA e em pacientes submetidos à ICP. Considerável variabilidade interindividual é observada nas respostas evocadas pelos diferentes inibidores de função plaquetária. Essa variabilidade está associada à elevada taxa de eventos adversos cardiovasculares. Parte dessa heterogeneidade é explicada por polimorfismos genéticos...

Não campactação isolada do miocárdio ventricular esquerdo: relato de caso / Isolated non-compaction of left ventricular myocardium: case report

Mulher de 35 anos solicitou serviço de cardiologia para avaliação clínica. Apresentava dispneia aos grandes esforços, palpitações e síncope. O eletrocardiograma apresentava extrassístoles ventriculares monomórficas e alteração de repolarização ventricular difusa em parede anterior. A ecocardiografia evidenciou não compactação isolada de miocárdio de ventrículo esquerdo, confirmado pela ressonância magnética. Prescreveu-se atenolol e foi indicado estudo eletrofisiológico e posterior ablação com melhora eletrocardiográfica. A conduta após resolução foi acompanhamento clínico, encontrando-se a paciente assintomática e sem medicações. São discutidos mecanismos fisiopatológicos relacionados a não compactação isolada de miocárdio ventrícular esquerdo, implicações clínicas e abordagem diagnóstica terapêutica.

Hiperglicemia de estresse na sindrome coronariana aguda: controle e importância prognóstica: [revisão] / Stress hyperglycemia in acute coronary syndrome: control and prognostic importance: [review]

A insuficiência cardíaca é atualmente uma importante complicação das síndromes coronarianas agudas, e agrava de forma considerável o prognóstico intra e extrahospitalar. A presença da diabetes melito é classicamente un fator de risco para desenvolvimento de infarto agudo do miocárdio e insuficiência cardíaca, sendo um problema de alta prevalência com crescimento epidêmico na população mundial. A hiperglicemia de estresse está presente ente 25 a 50 por cento dos pacientes admitidos com sindrome coronariana aguda e associam-se ao risco de complicações, intra-hospitalares tanto em pacientes com e sem diabetes melito, sendo marcador de pior prognóstico para mortalidade, IC e choque cardiogênico. A abordagem terapêutica da hiperglicemia de estresse na síndrome coronária aguda é ainda controversa, não havendo consenso sobre o melhor método de mensuraçãoglicêmica assim como o melhor tipo de tratamento. O objetivo deste artigo é revisar o estado da arte entre aassociação da hiperglicemia de estresse e a incidência de insuficiência cardíaca após a síndrome coronariana aguda.

Heart failure is currently an important complication of acute coronary syndromes, with significantly poorerprognoses, both in and out of hospital. The presence of diabetes mellitus is classically a risk factor for thedevelopment of acute myocardial infarction and heart failure, constituting a highly prevalent problem that isexpanding like an epidemic through the world’s population. Stress hyperglycemia is present in 25% to 50% of patients admitted with acute coronary syndrome,associated with the risk of in-hospital complications for patients with and without diabetes mellitus, being amarker for poor prognosis in terms of death, heart failure and cardiogenic shock. The therapeutic approach to stress hyperglycemia in acute coronary syndrome is still controversial, with no consensus on the best glucosemeasurement method nor the best type of treatment. The purpose of this paper is to review the state of the art of the association between stress hyperglycemia and the incidence of heart failure after acute coronary syndrome.

Sintomas depressivos e hospitalizações por insuficiência cardíaca: prevalência, preditores e mortalidade / Depressive symptoms and hospitalizations for heart failure: prevalence, predictors and mortality

Fundamentos. Estudos sobre sintomas depressivos (SD) têm sido feitos em pacientes hospitalizados por insuficiência cardíaca (IC) e tem sido ignorada a influência de várias características. Objetivos. Avaliar prevalência, preditores e correlação da gravidade dos SD e a mortalidade em hospitalizações por IC. Métodos. Estudo prospectivo que analisou hospitalizações consecutivas por IC. Foram analisados dados sociodemográficos, clínicos e o desfecho considerado foi óbito. Na análise dos SD foi utilizado o Inventário de Depressão de Beck. Foi feita análise comparativa entre grupos com e sem SD e submetidos a regressão logística as variáveis com p entre 0,05 e 0,1. Avaliou-se a relação entre a gravidade de SD e mortalidade. Foi utilizado teste qui-quadrado ou exato de Fisher para variáveis categóricas e t de student para contínuas. Foi considerado estatisticamente significante p<0,05. Resultados. Foram avaliados 103 pacientes, sendo 63,1% mulheres, 50,5% casados e alfabetizados 73,8%. O total de 75,2% estava em classe funcional II e III de New York Heart Association (NYHA). Hipertensão arterial sistêmica foi a comorbidade mais comum (92,2%). A presença de SD foi presente em 69 (67%) pacientes. Os preditores de SD foram: estado civil (p=0,03) e na regressão logística: sexo (p<0,0001), modo de vida (0,002) e etiologia da IC (p<0,0001). A mortalidade relacionou-se à SD em sintomas moderados (p=0,04) e graves (0,01). Conclusão. Os SD são comuns em hospitalizações por IC. A prevalência varia conforme características clínicas dos pacientes. Os preditores foram sexo, estado civil, modo de vida e etiologia da IC. A mortalidade relacionouse a SD moderados e graves.

Background. Studies of depressive symptoms (DS) has been made in patients hospitalized for heart failure (HF) and the influence of various characteristics has been ignored. Objectives. To assess prevalence, predictors and correlated to the severity of DS and mortality in HF hospitalizations. Methods. This prospective study examined consecutive hospitalizations for HF. We analyzed sociodemographic data and clinical outcome was death. In analysis of DS was used Beck Depression Inventory II. Comparative analysis were made between groups with and without DS and subjected to logistic regression variables with p between 0.05 and 0.1. We evaluated the relationship between the severity of SD and mortality. It was considered statistically significant p <0.05. Results: We evaluated 103 patients, 63.1% women, 50.5% were married and 73.8% literate. A total of 75.2% were in New York Heart Association (NYHA) functional class II and III. Hypertension was the most common comorbidity (92.2%). The DS was present in 69 (67%) patients. The predictors of DS were: marital status (p=0.03) and logistic regression: sex (p<0.0001), lifestyle (0.002) and etiology of HF (p<0.0001). Mortality was related to the DS in moderate symptoms (p=0.04) and severe (0.01). Conclusion. The DS are common in HF hospitalizations. The prevalence varies according to clinical characteristics of patients. The predictors were gender, marital status, lifestyle and etiology of HF. Mortality was related to moderate and severe DS.

Análise de um modelo de risco pré-operatório específico para cirurgia valvar e a relação com o tempo de internação em unidade de terapia intensiva / Analysis of specific pre-operative model to valve surgery and relationship with the length of stay in intensive care unit

OBJETIVOS: O tempo de internação prolongado após cirurgia cardíaca é associado a resultados imediatos ruins e aumento dos custos. O objetivo deste estudo foi analisar o poder preditor do escore de Ambler na previsão do tempo de internação em unidade de terapia intensiva. MÉTODOS: Estudo de coorte retrospectiva com dados coletados de 110 pacientes submetidos à cirurgia de troca valvar isolada ou associada. Os valores do escore aditivo e logístico do escore de Ambler e as performances preditivas do escore de Ambler foram obtidos por meio da curva ROC. A estadia em unidade de terapia intensiva definiu-se como normal <3 dias e prolongada >3 dias. A área sobre as curvas dos modelos aditivo e logístico foram comparadas por meio do teste de Hanley-MacNeil. RESULTADOS: A média de permanência em unidade de terapia intensiva foi de 4,2 dias. Sessenta e três pacientes pertenciam ao sexo masculino. O modelo logístico apresentou área sob a curva ROC de 0,73 e 0,79 para internação >3 dias e <3 dias, respectivamente, apresentando bom poder discriminatório. No modelo aditivo, as áreas foram 0,63 e 0,59 para internação >3 dias e <3 dias, respectivamente, sem bom poder discriminatório. CONCLUSÕES: Em nossa base de dados, o tempo de internação prolongado em unidade de terapia intensiva foi positivamente correlacionado com o escore de Ambler logístico. O desempenho do escore de Ambler logístico teve bom poder preditor para correlação do tempo de internação em unidade de terapia intensiva.

OBJECTIVES: The length of stay after prolonged cardiac surgery has been associated with poor immediate outcomes and increased costs. This study aimed to evaluate the predictive power of the Ambler Score to anticipate the length of stay in the intensive care unit. METHODS: This was a retrospective cohort study based on data collected from 110 patients undergoing valve replacement surgery alone or in combination with other procedures. Additive and logistic Ambler Scores were obtained and their predictive performances calculated using the Receiver Operating Characteristic curve. The normal length stay in the intensive care unit was assumed to be <3 days and prolonged >3 days. The areas under the receiver operating curves for both the additive and logistic models were compared using the Hanley-MacNeil test. RESULTS: The mean intensive care unit length of stay was 4.2 days. Sixty-three patients were male. The logistic model showed areas under the receiver operating characteristic curve of 0.73 and 0.79 for hospitalization > 3 days and < 3 days, respectively, showing good discriminative power. For the additive model, the areas were 0.63 and 0.59 for hospitalization > 3 days and < 3 days, respectively, a poor discriminative power. CONCLUSIONS: In our database, prolonged length of stay in the intensive care unit was positively correlated with the logistic Ambler score. The performance of the logistic Ambler Score had good discriminative power for correlation with the intensive care unit length of stay.

Revascularização miocárdica no idoso: experiência de 107 casos / Coronary artery bypass grafts in the elderly: 107 case studies

Diante do avanço da doença coronariana no mundo, torna-se cada vez mais importante a viabilidade da cirurgia de revascularização do miocárdio, aumentando a sobrevida e a qualidade de vida de pacientes coronariopatas idosos. Apresentar resultados imediatos das cirurgias de revascularização miocárdica isoladas em pacientes maior ou igual a 70 anos. No período de janeiro de 2003 a outubro de 2008, 107 pacientes foram revisados retrospectivamente com apresentação descritiva dos resultados imediatos...

Reparo endovascular de aneurisma de aorta torácica: experiência de 16 casos / Stent-graft repair of thoracic aortic aneurism: experience of 16 cases

Os aneurismas dissecantes e as rupturas de aorta torácica têm sido de difícil resolução. O reparo endovascular de aneurisma de aorta torácica apresenta considerável potencial e vantagens sobre a abordagem cirúrgica como tratamento, devido em parte ao reparo cirúrgico estar associado a altas taxas de mortalidade. Relatar a experiência com uso de endopróteses auto-expansíveis no tratamento de pacientes selecionados, portadores de aneurismas ou dissecções comprometendo...